The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rudenko T.E.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Bobkova I.N.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Kamyshova E.S.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Gorelova I.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Role of the mechanisms of replicative cellular senescence in structural and functional changes of the vascular wall in chronic kidney disease

Authors:

Rudenko T.E., Bobkova I.N., Kamyshova E.S., Gorelova I.A.

More about the authors

Journal: Therapeutic Archive. 2017;89(6): 102‑109

DOI: 10.17116/terarkh2017896102-109

Views: 1281

Downloaded: 521

Download PDF (RU)
Contact the author
Table of contents

ROLE OF THE MECHANISMS OF REPLICATIVE CELLULAR SENESCENCE IN STRUCTURAL AND FUNCTIONAL CHANGES OF THE VASCULAR WALL IN CHRONIC KIDNEY DISEASE
ROLE OF THE MECHANISMS OF REPLICATIVE CELLULAR SENESCENCE IN STRUCTURAL AND FUNCTIONAL CHANGES OF THE VASCULAR WALL IN CHRONIC KIDNEY DISEASE

To cite this article:

Rudenko TE, Bobkova IN, Kamyshova ES, Gorelova IA. Role of the mechanisms of replicative cellular senescence in structural and functional changes of the vascular wall in chronic kidney disease. Therapeutic Archive. 2017;89(6):102‑109. (In Russ.)
https://doi.org/10.17116/terarkh2017896102-109

МСФ на ЯМ
Close metadata
Recommended articles:
Thoracoscopic rese­ction of recu­rrent atypically loca­ted para­thyroid adenoma of ante­rior mediastinum in a patient with hype­rparathyroidism unde­rgoing renal replacement therapy. Piro­gov Russian Journal of Surgery. 2024;(6):81-87
Dige­stive system diseases and a chro­nic kidney disease — the two sides of the healthcare global problems. Russian Journal of Preventive Medi­cine. 2024;(7):108-113
Clinical consequences of sarcopenic obesity. Part 1. Non-alcoholic fatty liver disease, type 2 diabetes mellitus, chro­nic kidney disease. Russian Journal of Preventive Medi­cine. 2024;(8):114-120
Perioperative mana­gement of patients with coro­nary artery disease. Guidelines of the All-Russian Public Orga­nization “Federation of Anaesthesiologists and Reanimatologists” (the 2nd revi­sion). Russian Journal of Anesthesiology and Reanimatology. 2024;(5):6-28
Modern scientific and practical approaches to searching for biomarkers of aging. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(3):46-52
Asso­ciation of smoking with the troponin I level and adve­rse cardiovascular events. Russian Journal of Preventive Medi­cine. 2024;(9):52-59
Possibilities of coro­nary artery calcification asse­ssment for cardiovascular risk stra­tification. Russian Journal of Preventive Medi­cine. 2024;(9):117-122
Feasibility of application in the practice of dental diseases of meta­bolic changes in bone tissue in examination of patients with chro­nic kidney disease. Russian Journal of Stomatology. 2024;(3):16-22
Asse­ssment of risk of deve­loping fractures and sarcopenia and quality of life of patients with chro­nic kidney disease at the outpatient stage. Russian Journal of Preventive Medi­cine. 2024;(12):88-91
The role of quantitative body composition analysis in popu­lation in the asse­ssment and moni­toring of cardiovascular risk meta­bolic factors. Russian Journal of Preventive Medi­cine. 2024;(12):128-134

This review considers the mechanisms and risk factors for the development of replicative cellular senescence of the vascular wall in patients with CKD and discusses therapeutic approaches to slowing the accelerated vascular aging.

Keywords:

telomeres
telomerase
chronic kidney disease
cardiovascular risk

Authors:

Rudenko T.E.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Bobkova I.N.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Kamyshova E.S.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Gorelova I.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

List of references:

  1. Whaley-Connell A, Sowers J, Stevens L, McFarlane S, Shlipak M, Norris K, Chen SC, Qiu Y, Wang C, Li S, Vassalotti J, Collins A. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. American Journal of Kidney Diseases. 2008;51(4):S13-S20 doi:10.1053/j.ajkd.2007.12.016
  2. Collins A, Foley R, Gilbertson D, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney International Supplements. 2015;5(1):2-7. doi:10.1038/kisup.2015.2
  3. Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, Kawagishi T, Tahara H, Ishimura E, Nishizawa Y. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney International. 2002;61(6):2187-2192 doi:10.1046/j1523-1755.2002.00372.x
  4. London G, Marchais S, Guérin A, Métivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Current Opinion in Nephrology and Hypertension. 2005;14 (6):525-531. doi:10.1097/01.mnh.0000168336.67499.c0
  5. Sarnak M, Levey A. Cardiovascular disease and chronic renal disease: a new paradigm. American Journal of Kidney Diseases. 2000;35 (4);S117-S131. doi:10.1016/s0272-6386(00)70239-3
  6. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrology Dialysis Transplantation. 2002;17(suppl.11):50-54. doi:10.1093/ndt/17.suppl_11.50
  7. Briet M, Burns KD. Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clinical Science. 2002;123:399-416. doi:10.1042/cs20120074
  8. Stenvinkel P, Larsson T. Chronic kidney disease: a clinical model of premature aging. American Journal of Kidney Diseases. 2013; 62(2):339. doi:10.1053/j.ajkd.2012.11.051
  9. Kooman JP, Kotanko P, Schols A, Shiels P, Stenvinkel P. Chronic kidney disease and premature ageing. Nature Reviews Nephrology. 2014;10(12):732-742. doi:10.1038/nrneph.2014.185
  10. Nilsson P, Tufvesson H, Leosdottir M, Melander O. Telomeres and cardiovascular disease risk: an update 2013. Translational Research. 2013;162(6):371-80. doi:10.1016/j.trsl.2013.05.004
  11. Wong LS, Oeseburg H, de Boer RA, van Gilst WH, van Veldhuisen DJ, van der Harst P. Telomere biology in cardiovascular disease:the TERC−/− mouse as a model for heart failure and ageing. Cardiovascular Research. 2009;81(2):244-252. doi:10.1093/cvr/cvn337
  12. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Research. 2007;35(22):7417-7428. doi:10.1093/nar/gkm681
  13. Reaper PM, di Fagagna F, Jackson SP. Activation of the DNA damage response by telomere attrition: a passage to cellular senescence. Cell Cycle. 2004;3 (5):543-546. doi:10.4161/cc.3.5.835
  14. Drapkina O, Shepel’ R. Sovremennye predstavleniya o roli telomer i telomerazy v patogeneze gipertonicheskoi bolezni. Arterial’naya gipertenziya. 2013;19(4):290-298. (In Russ.)
  15. Yeh JK, Wang CY. Telomeres and telomerase in cardiovascular diseases. Genes. 2016;7(9). pii:E58. doi:10.3390/genes7090058
  16. Ahmed A, Tollefsbol T. Telomeres and telomerase: basic science implications for aging. Journal of the American Geriatrics Society. 2001;49(8):1105-1109. doi:10.1046/j.1532-5415.2001.49217.x
  17. Richardson GD, Breault D, Horrocks G, Cormack S, Hole N, Owens W. Telomerase expression in the mammalian heart. The FASEB Journal. 2012;26:4832-4840. doi:10.1096/fj.12-208843
  18. Takubo K, Izumiyama-Shimomura N, Honma N, Sawabe M, Arai T, Kato M, Nakamura KI. Telomere lengths are characteristic in each human individual. Experimental Gerontology. 2002;37(4):523-553. doi:10.1016/s0531-5565(01)00218-2
  19. Cristofalo VJ, Lorenzini A, Allen RG, Torres C, Tresini M. Replicative senescence: a critical review. Mechanisms of Ageing and Development. 2004;125(10-11):827-848. doi:10.1016/j.mad.2004.07.010
  20. Edo M, Andre´s V. Aging, telomeres, and atherosclerosis. Cardiovascular Research. 2005;66:213-221. doi:10.1016/j.cardiores.2004.09.007
  21. Yin H, Pickering G. Cellular senescence and vascular disease: novel Routes to better understanding and therapy. Canadian Journal of Cardiology. 2016:32(5);612-623. doi:10.1016/j.cjca.2016.02.051
  22. Adaikalakoteswari A, Balasubramanyam M, Ravikumar R, Deepa R, Mohan V. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis. 2007;195(1):83-89. doi:10.1016/j.atherosclerosis.2006.12.003
  23. Valdes AM, Andrew T, Gardner P, Kimura M, Oelsener E, Cherkas LF, Aviv A, Spector TD. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366:662-664. doi:10.1016/S0140-673666630-5
  24. Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A, Kimura M, Larson MG, Meigs JB, Keaney JF, Aviv A. Insulin resistance, oxidative stress, hypertension, and leukocyte length in men from the Framingham Heart Study. Aging Cell. 2006;5:325-330. doi:10.1111/j.1474-9726.2006.00224.x
  25. Epel ES, Lin J, Wilhelm FH, Wolkowitz OM, Cawthon R, Adler NE, Dolbier C, Mendes WB, Blackburn EH. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 2006;3:277-287. doi:10.1016/j.psyneuen.2005.08.011
  26. Minamino T, Komuro I. Role of telomere in endothelial dysfunction in atherosclerosis. Current Opinion in Lipidology. 2002; 13(5):537-543. doi:10.1097/00041433-200210000-00010
  27. Aviv H. Khan MY, Skurnick J, Okuda K, Kimura M, Gardner J, Priolo l, Aviv A. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis. 2001;159:281-287. doi:10.1016/s0021-9150(01)00506-8
  28. Chang E, Harley C. Telomere length and replicative aging in human vascular tissues. Proceedings of the National Academy of Sciences. 1995;92(24):11190-11194. doi:10.1073/pnas.92.24.11190
  29. Okuda K, Khan M, Skurnick J, Kimura M, Aviv H, Aviv A. Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis. 2000;152:391-398. doi:10.1016/s0021-9150(99)00482-7
  30. Minamino T, Miyauchi, H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation. 2002;105:1541-1544. doi:10.1161/01.CIR.0000013836.85741.17
  31. Vasa M, Breitschopf K, Zeiher AM, Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circulation Research. 2000;87:540-542. doi:10.1161/01.RES.87.7.540
  32. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF, Kamalanathan S, Hattori Y, Ignarro LJ, Iguchi A. Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes. Proceedings of the National Academy of Sciences. 2006;103:17018-17023. doi:10.1073/pnas.0607873103
  33. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress. Circulation Research. 2006;99:156-164. doi:10.1161/01.RES.0000233315.38086.bc
  34. Gorenne I, Kavurma M, Scott S, Bennett M. Vascular smooth muscle cell senescence in atherosclerosis. Cardiovascular Research. 2006;72(1):9-17. doi:10.1016/j.cardiores.2006.06.004
  35. Minamino T, Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ Res. 2001;89:237-243. doi:10.1161/hh1501.094267
  36. Wang J, Uryga A, Reinhold J, Figg N, Baker L, Finigan A, Gray K, Kumar S, Clarke M, Bennett M. Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation. 2015;132:1909-1919. doi:10.1161/CIRCULATIONAHA.115.016457
  37. Pykhtina B, Strazhesko I, Agal’tsov M, Tkacheva O. Renin-angiotenzin-al’dosteronovaya sistema i replikativnoe kletochnoe starenie: ikh vzaimodeistvie v khode stareniya sosudov. Ratsional’naya Farmakoterapiya v Kardiologii. 2014;10(3):312-316. (In Russ.)
  38. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis. 2007;194;46-54. doi:10.1016/j.atherosclerosis.2007.03.046
  39. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circulation Research. 2004;95:343-353. doi:10.1161/01.res.0000137877.89448.78
  40. Chen J, Goligorsky MS. Premature senescence of endothelial cells: Methusaleh’s dilemma. AJP: Heart and Circulatory Physiology. 2006;290:1729-1739. doi:10.1152/ajpheart.01103.2005
  41. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. American College of Cardiology. 2005;45:1441-1448. doi:10.1016/j.jасс.2004.12.074
  42. Tsirpanlis G. Cellular Senescence, Cardiovascular Risk, and CKD: A Review of Established and Hypothetical Interconnections. American Journal of Kidney Diseases. 2008;51:131-144. doi:10.1053/j.ajkd.2007.07.035
  43. Aviv A. Leukocyte Telomere Length, Hypertension, and Atherosclerosis Are There Potential Mechanistic Explanations? Hypertension. 2009;53:590-591. doi:10.1161/HYPERTENSIONAHA.109.128926
  44. Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clinical and Experimental Pharmacology and Physiology. 2004;31:407-410. doi:10.1111/j.1440-1681.2004.04022.x
  45. Fujii H, Li SH, Szmitko PE, Fedak P, Verma S. C-Reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2476-2482. doi:10.1161/01.atv.0000242794.65541.02
  46. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. Journal of Hypertension. 2005;23:1831-1837. doi:10.1097/01.hjh.0000183524.73746.1b
  47. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo D.W, Asahara T, Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation. 2002;106:1133-1139. doi:10.1161/01.CIR.0000027584.85865.B4
  48. Daniali L, Benetos A, Susser E, Kark JD, Labat C, Kimura M, Desai K, Granick M, Aviv A. Telomeres shorten at equivalent rates in somatic tissues of adults. Nature Communications. 2013; 4:1597. doi:10.1038/ncomms2602
  49. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003; 23:842-846. doi:10.1161/01.ATV.0000067426.96344.32
  50. D’Mello M, Ross S, Briel M, Anand S, Gerstein H, Paré G. Association between shortened leukocyte telomere length and cardiometabolic outcomes: Systematic review and meta-analysis. Circulation: cardiovascular genetics. 2015;8:82-90. doi:10.1161/CIRCGENETICS.113.000485.
  51. Brouilette SW, Moore J, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: A nested case-control study. Lancet. 2007;369:107-114. doi:10.1016/s0140-6736(07)60071-3
  52. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ. 2014; 349:g4227-g4227. doi:10.1136/bmj.g4227
  53. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet. 2001;358:472-473. doi:10.1016/s0140-6736(01)05633-1
  54. Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J, Labat C, Bean K, Aviv A. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension. 2001;37(2):381-385. doi:10.1161/01.hyp.37.2.381
  55. Benetos A, Gardner JP, Zureik M, Labat C, Xiaobin L, Adamopoulos C, Temmar M, Bean KE, Thomas F, Aviv A. Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive Subjects. Hypertension. 2004;43:182-185. doi:10.1161/01.HYP.0000113081.42868.f4
  56. Dudinskaya E, Tkacheva O, Shestakova M, Brailova N, Strazhesko I, Akasheva D, Isaykina O, Pokrovskaya M, Sharashkina N, Boytsov S. Telomere length and vascular wall in patients with type 2 diabetes mellitus. Diabetes mellitus. 2014;(3):31-38. (In Russ.) doi:10.14341/dm2014331-38
  57. White WE, Yaqoob MM, Harwood SM. Aging and uremia: Is there cellular and molecular crossover? World Journal of Nephrology. 2015;4(1):19-30. doi:10.5527/wjn.v4.i1.19
  58. Golygorsky M, Yasuda K, Ratliff B. Dysfunctional endothelial progenitor cells in chronic kidney disease. Journal of the American Society of Nephrology. 2010;21:911-919. doi:10.1681/asn.2009111119
  59. Kordinas V, Ioannidis A, Chatzipanagiotou S. The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? Genes. 2016:7(9):60-82. doi:10.3390/genes7090060
  60. Torres P-Ureña, Prie´ D, Molina-Blétry V, Beck L, Silve C, Friedlander G. Klotho: An antiaging protein involved in mineral and vitamin D metabolism. Kidney International. 2007;71(8):730-737. doi:10.1038/sj.ki.5002163
  61. Rudenko T, Kutyrina I, Kushnir V, Shvetsov M. Faktory, vliyayushchie na sostoyanie kompleksa intima-mediya sonnykh i bedrennykh arterii v nachal'nykh stadiyakh khronicheskoi pochechnoi nedostatochnosti. Terapevticheskii arkhiv. 2005;6:46-50. (In Russ.)
  62. Henry Ronald MA, Kostense Piet J, Bos G., Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney International. 2002;62:S1402-S1407. doi:10.1046/j.1523-1755.2002.00571.x
  63. Nanayakkara PWB, Gaillar CAJM. Vascular disease and chronic renal failure: new insights. The Netherlands Journal of Medicine. 2010;68(1):5-14.
  64. Adijiang A, Higuchi Y, Nishijima F, Shimizu H, Niwa T. Indoxyl sulfate, a uremic toxin, promotes cell senescence in aorta of hypertensive rats. Biochemical and Biophysical Research Communications. 2010;399:637-641. doi:10.1016/j.bbrc.2010.07.130
  65. Muteliefu G, Shimizu H, Enomoto A, Nishijima F, Takahashi M, Niwa T. Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. AJP: Cell Physiology. 2012;303:C126-C134. doi:10.1152/ajpcell.00329.2011
  66. Carracedo J, Merino A, Briceño C, Soriano S, Buendía P, Calleros L, Rodriguez M, Martín-Malo A, Aljama P, Ramírez R. Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. The FASEB Journal. 2011;25:1314-1322. doi:10.1096/fj.10-173377
  67. Klinkhammer BM, Kramann R, Mallau M, Makowska A, van Roeyen CR, Rong S, Buecher EB, Boor P, Kovacova K, Zok S, Denecke B, Stuettgen E, Otten S, Floege J, Kunter U. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS One. 2014;9:e92115. doi:10.1371/journal.pone.0092115
  68. Ramirez R, Carracedo J, Soriano S, Jiménez R, Martín-Malo A, Rodríguez M, Blasco M, Aljama P. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. American Journal of Kidney Diseases. 2005;45(2):353-359. doi:10.1053/j.ajkd.2004.10.022
  69. Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Alevyzaki F, Zoga M, Kyritsis I, Stamatelou K, Triantafyllis G, Nicolaou C. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. American Journal of Nephrology. 2006;26:91-96. doi:10.1159/000092031
  70. Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Zoga M, Alevyzaki F, Stamatelou K, Frangou E, Savva L, Nicolaou C. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients. Nephrology. 2006;11(6):506-509. doi:0.1111/j.1440-1797.2006.00697.x
  71. Stefanidis I, Voliotis G, Papanikolaou V, Chronopoulou I, Eleftheriadis T, Kowald A, Zintzaras E, Tsezou A. Telomere length in peripheral blood mononuclear cells of patients on chronic hemodialysis is related with telomerase activity and treatment duration. Artificial Organs. 2015:39 (9):756-764. doi:10.1111/aor.12453
  72. Kordinas V, Tsirpanlis G, Nicolaou C, Zoga M, Ioannidis A, Ioannidou V, Bersimis S, Petrihou C, Savva L, Legakis NJ, Chatzipanagiotou S. Is there a connection between inflammation, telomerase activity and the transcriptional status of telomerase reverse transcriptase in renal failure? Cellular and Molecular Biology Letters. 2015:20 (2):222-236. doi:10/1515/cmble-2015-0016
  73. Hirashio S, Nakashima A, Doi S, Anno K, Aoki E, Shimamoto A, Yorioka N, Kohno N, Masaki T, Tahara H. Telomeric G-Tail length and hospitalization for cardiovascular events in hemodialysis patients. Clinical Journal of the American Society of Nephrology. 2014;9:2117-2122. doi:10.2215/CJN.10010913
  74. Markkanen E, van Loon B, Ferrari E, Parsons JL, Dianov GL, Hu¨bscher U. Regulation of oxidative DNA damage repair by DNA polymerase and MutYH by cross-talk of phosphorylation and ubiquitination. Proceedings of the National Academy of Sciences. 2012;109:437-442. doi:10.1073/pnas.1110449109
  75. Carrero JJ, Stenvinkel P, Fellström B, Qureshi AR, Lamb K, Heimbürger O, Barany, Radhakrishnan P, Lindholm B, Soveri I, Nordfors L, Shiels PG. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. Journal of Internal Medicine. 2007;263:302-312. doi:10.1111/j.1365-2796.2007.01890.x
  76. Panickar K, Jewell DE. The beneficial role of anti-inflammatory dietary ingredients in attenuating markers of chronic low-grade inflammation in aging. Hormone Molecular Biology and Clinical Investigation. 2015;23:59-70. doi:10.1515/hmbci-2015-0017
  77. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJM, Marlin R, Yglecias L, Carroll PR, Blackburn EH. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. The Lancet Oncology. 2008;9(11):1048-1057. doi:10.1016/s1470-2045(08)70234-1
  78. Duraimani S, Schneider RH, Randall OS, Nidich S, Xu S, Ketete M, Rainforth MA, Gaylord-King C, Salerno JW, Fagan J. Effect of life modification on telomerase gene expression Effects of Lifestyle Modification on Telomerase Gene Expression in Hypertensive Patients: A Pilot Trial of Stress Reduction and Health Education Programs in African Americans. PLOS ONE. 2015;10(11):e0142689. doi:10.1371/journal.pone.0142689
  79. Spyridopoulos I, Haendeler J, Urbich C, et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation. 2004;110(19):3136-3142. doi:10.1161/01.cir.0000142866.50300.eb
  80. Strazhesko I, Tkacheva O, Akasheva D, Dudinskaya E, Plokhova E, Pykhtina V, Kruglikova A, Kokshagina N, Sharashkina N, Agaltsov M, Kashtanova D, Vygodin V, Ozerova I, Skvortsov D, Vasilkova D, Boytsov S. Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases. Frontiers in Pharmacology. 2016;7:347. doi:10.3389/fphar.2016.00347
  81. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885-2890. doi:10.1161/hc2401.092816
  82. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002;105:3017-3024. doi:10.1161/01.CIR.0000018166.84319.55
  83. Schupp N, Schmid U, Heidland A, Stopper H. Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis. Atherosclerosis. 2008;199(2):278-287. doi:10.1016/j.atherosclerosis.2007.11.016
  84. Barden A, O’Callaghan N, Burke V, Mas E, Beilin LJ, Fenech M, Irish AB, Watts GF, Puddey IB, Huang RC, Mori TA. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease. Nutrients. 2016;8:175. doi:10.3390/nu8030175
  85. Donnini S, Terzuoli E, Ziche M, Morbidelli L. Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk. Journal of Pharmacology and Experimental Therapeutics. 209;332:776-784. doi:10.1124/jpet.109.159178
  86. Werner C, Gensch C, Pöss J, Haendeler J, Böhm M, Laufs U. Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis. Atherosclerosis. 2011;216:23-34. doi:10.1016/j.atherosclerosis.2011.02.011
  87. BärC, de Jesus BB, Serrano R, Tejera A, Ayuso E, Jimenez V, Formentini I, Bobadilla M, Mizrahi J, de Martino A, Gomez G, Pisano D, Muleo F, Wollert KC, Bosch F, Blasco MA. Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction. Nature Communication. 2014. doi:10.1038/ncomms6863
  88. Oh H, Schneider MD. The emerging role of telomerase in cardiac muscle cell growth and survival. Journal of Molecular and Cellular Cardiology. 2002;34:717-724. doi:10.1006/jmcc.2002.2018
  89. González-Suárez E, Geserick C, Flores J, Blasco M, Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene. 2005;24:2256-2270. doi:10.1038/sj.onc.1208413
  90. Samper E, Flores JM, Blasco MA. Restoration of telomerase activity rescues chromosomal instability and premature aging in TERC−/− mice with short telomeres. EMBO reports. 2001;2:800-807. doi:10.1093/embo-reports/kve174

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.